Maze Therapeutics (MAZE) Return on Sales (2024 - 2026)

Maze Therapeutics (MAZE) has 3 years of Return on Sales data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales fell 1.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.05% (down 4.0% YoY), and the FY2024 full-year result was 0.03%, changed N/A from the prior year.
• Return on Sales retreated to 0.01% in Q1 2026, from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.09% in Q2 2024 to a low of 0.1% in Q3 2024.
• A 3-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Sales.
• Peak annual rise in Return on Sales reached 11 bps in 2025, while the deepest fall reached 8 bps in 2025.
• Tracing MAZE's Return on Sales over 3 years: stood at 0.0% in 2024, then surged by 244 bps to 0.01% in 2025, then sank by 210 bps to 0.01% in 2026.
• Business Quant data shows MAZE's Return on Sales at 0.01% in Q1 2026, 0.01% in Q3 2025, and 0.01% in Q2 2025.